ATS View
한국어

Yuyu Pharma KRX:000220KOSPI

유유제약 · Korean news coverage and regulatory filings, organized.

한국어
Articles, 24h15
Articles, 7 days27
DART filings, 7 days0
Articles tracked114since Sep 11

In Q2 2026, Yuyu Pharma reported revenue of ₩36.7bn, up 2.4% year on year, and operating profit of ₩4.0bn. Yuyu Pharma (유유제약) appeared in 27 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Oct 19 with 25 articles. The most common catalyst was tech & capacity (1).

Filing signals Profit +50% Screener

Yuyu Pharma quarterly results consolidated, KRW

QuarterRevenueYoYOperating profitNet income
Q2 2026₩36.7bn+2.4%₩4.0bn
margin 10.9%		₩3.6bn
Q1 2026₩35.5bn+8.0%₩4.3bn
margin 12.1%		₩3.4bn
Q4 2025 derived₩34.3bn+4.2%−₩129m
margin −0.4%		₩1.2bn
Q3 2025₩37.8bn+12.5%₩5.0bn
margin 13.2%		₩4.3bn
Q2 2025₩35.8bn+8.0%₩2.2bn
margin 6.3%		₩592m
Q1 2025₩32.9bn-1.5%₩3.9bn
margin 11.9%		₩3.0bn
Q4 2024 derived₩33.0bn-4.7%−₩268m
margin −0.8%		−₩605m
Q3 2024₩33.6bn-1.4%₩3.5bn
margin 10.5%		₩3.3bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

Yuyu Pharma top stories 2 weeks, by number of outlets

  1. 1
    유유제약, 복합제형 플랫폼 '유니캡' 개발
    11 outlets · 12 articlesFirst report Oct 19 08:13 핀포인트뉴스
  2. 2
    유유제약, 복합제형 플랫폼 기술 ‘YUNICAP’ 개발 및 상표 등록 완료
    9 outlets · 9 articlesFirst report Oct 19 08:50 더바이오
  3. 3
    유유제약, 환절기 코 건강 관리 제품 라인업 확장
    4 outlets · 4 articlesFirst report Oct 27 09:38 뉴스1
  4. 4
    유유제약 유원상 대표, BIX 2026서 동물의약품 사업화 비전 제시
    3 outlets · 3 articlesFirst report Oct 30 08:53 메디파나뉴스
  5. 5
    유원상 유유제약 “반려동물 의약품, 신약 임상 출발점”
    3 outlets · 3 articlesFirst report Oct 30 09:35 위키리크스한국
  6. 6
    유유제약, 서로 다른 약 하나의 캡슐에…복합제 기술 '유니캡' 개발
    2 outlets · 2 articlesFirst report Oct 19 13:07 메디컬투데이

Latest Yuyu Pharma news Korean headlines